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The 30 end of the rRNA of the small ribosomal subunit
contains two extremely highly conserved dimethy-
lated adenines. This modification and the respon-
sible methyltransferases are present in all three
domains of life, but its function has remained elusive.
We have disrupted the mouse Tfb1m gene encoding
a mitochondrial protein homologous to bacterial di-
methyltransferases and demonstrate here that loss
of TFB1M is embryonic lethal. Disruption of Tfb1m
in heart leads to complete loss of adenine dimethyla-
tion of the rRNA of the small mitochondrial ribosomal
subunit, impaired assembly of the mitochondrial
ribosome, and abolished mitochondrial translation.
In addition, we present biochemical evidence that
TFB1M does not activate or repress transcription in
the presence of TFB2M. Our results thus show that
TFB1M is a nonredundant dimethyltransferase in
mammalian mitochondria. In addition, we provide
a possible explanation for the universal conservation
of adenine dimethylation of rRNA by showing a crit-
ical role in ribosome maintenance.
INTRODUCTION
The mitochondrial network of mammalian cells harbors the
oxidative phosphorylation system, which produces the bulk
part of cellular energy in the form of ATP to drive a variety of
metabolic reactions (Saraste, 1999). Deficient mitochondrial
energy production is heavily implicated in various types of
human pathologies, e.g., inherited diseases, age-related chronic
diseases, and the aging process (Wallace, 1999; Terzioglu and
Larsson, 2007). The biogenesis of the respiratory chain is
uniquely dependent on the coordinated expression of both
nucleus- and mtDNA-encoded subunits (Scarpulla, 2008).
However, only aminority of the respiratory chain subunits are en-
coded by mtDNA, but these subunits are nevertheless essential,
as disruption of mtDNA-expression leads to severely impaired
respiratory chain function (Larsson et al., 1998). The regulation
of mtDNA expression is under nuclear genetic control (Falken-386 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.berg et al., 2007), which further adds to the complexity involved
in coordinating cellular energy production.
Mitochondrial transcription factors B1 and B2 (TFB1M and
TFB2M, also denotedmtTFB1 andmtTFB2) are important exam-
ples of factors involved in regulation of mitochondrial gene
expression in mammalian cells (Falkenberg et al., 2002). Both
of these factors are nucleus encoded and imported to mitochon-
dria. Their expression is tightly regulated by nuclear transcription
factors that control mitochondrial biogenesis, i.e., the PGC-I
group of coactivators and the nuclear respiratory factors 1 and 2
(Gleyzer et al., 2005; Spiegelman, 2007; Scarpulla, 2008). In
mitochondria, TFB1M and TFB2M form heterodimers with mito-
chondrial RNA polymerase (POLRMT), and in vitro experiments
have demonstrated that both factors can activate mtDNA tran-
scription (Falkenberg et al., 2002). Surprisingly, the TFBM factors
may also have a role in translation, as they are related to a class
of methyltransferases present in all three domains of life, i.e., in
archaebacteria, eubacteria, and eukaryotes (cytosol and mito-
chondria) (Falkenberg et al., 2002; McCulloch et al., 2002; Shutt
and Gray, 2006). These enzymes dimethylate two adjacent
adenines in a stem-loop structure close to the 30 end of the small
subunit rRNA (Helser et al., 1971; Poldermans et al., 1979, 1980).
This rRNA modification is extremely highly conserved in nature,
and only a handful of organisms are known that lack it (Shutt
and Gray, 2006; Xu et al., 2008). In bacteria, the modified
adenine residues are present in a region of the small subunit of
the ribosome that contains the mRNA decoding center and the
binding site for the large ribosome subunit (Xu et al., 2008).
The critical location of the modified residues within the ribosome
and the extreme conservation suggest an important role in regu-
lation of translation. Unexpectedly, E. coli lacking this methyl-
transferase, denoted KsgA, and the corresponding small ribo-
somal subunit rRNA modification are viable with only a slight
growth disadvantage and gain resistance to the antibiotic kasu-
gamycin (Helser et al., 1971; vanBuul et al., 1984; Desai andRife,
2006; Xu et al., 2008). There are thusmany questions concerning
the role of this highly conserved modification that likely has an
important but yet unknown role in ribosome function. Studies
of the role for TFB1M and TFB2M in mammalian mitochondria
could therefore be a valuable strategy to increase our under-
standing in this area. Furthermore, there is also a need to defin-
itively resolve the dilemma concerning conflicting data of the
distinct roles for TFB1M and TFB2M in mammals. TFB2M has
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TFB1M Regulates Mitochondrial TranslationFigure 1. Conditional Knockout of Tfb1m and Phenotypes in Homozygous Knockout Embryos
(A) Targeting strategy for disruption of the Tfb1m genomic locus. Screening of ESCs was done using the indicated SpeI endonuclease cleavage sites (endog-
enous: black; introduced: red) and a probe outside the region of homology in the targeting vector.
(B) Southern blot analysis of tissues from wild-type (Tfb1m+/+), heterozygous targeted (Tfb1m+/loxP), and heterozygous knockout (Tfb1m+/) mice. SpeI digest
generates specific fragments of 11.2 kb (wild-type allele), 8.8 kb (targeted allele), and 6.8 kb (knockout allele).
(C) Morphological comparison between wild-type (Tfb1m+/+) and knockout (Tfb1m/) embryos at embryonic day E8.5. Tfb1m/ embryos have a mutant
morphology.
(D) Enzyme histochemical double staining for cytochrome c oxidase (COX;mitochondria-encoded) and succinate dehydrogenase (SDH; nucleus-encoded) activ-
ities in sections from Tfb1m+/+ and Tfb1m/ embryos. Blue staining indicates lack of COX activity in Tfb1m/ embryos. Magnification, 203.been reported to be at least an order of magnitude more active
than TFB1M in promoting in vitro transcription of mtDNA in a
pure recombinant system (Falkenberg et al., 2002), which
suggests that TFB1M is, at best, a very poor transcription factor.
Arguing against this interpretation, it has been reported that
addition of recombinant TFB1M to a mitochondrial extract
dramatically stimulates in vitro transcription of mtDNA (McCul-
loch et al., 2002; McCulloch and Shadel, 2003). On the other
hand, there are reports that both TFB1M and TFB2M act as
methyltransferases. First, both proteins have been reported to
have the capacity to bind s-adenosyl methionine, which is the
methyl donor for the methyltransferase reaction (Seidel-Rogol
et al., 2003; Cotney and Shadel, 2006). Second, expression of
either TFB1M or TFB2M can restore deficient methylation of
the small ribosomal subunit rRNA in bacteria lacking KsgA
(Seidel-Rogol et al., 2003; Cotney and Shadel, 2006). To address
the role of the highly conserved adenine dimethylation of the
small subunit rRNA and to elucidate possible distinct functions
of TFB1M and TFB2M, we have conditionally inactivated the
Tfb1m gene in the mouse.RESULTS
TFB1M Is Essential for Embryonic Development
in Mouse
We created a conditional Tfb1m knockout mouse to address the
in vivo function of TFB1M (Figure 1A). Heterozygous mice de-
rived from germline transmission of the targeted Tfb1m+/loxP-neo
allele were mated to Flp-deleter mice to remove the neomycin
selection marker, thus generating heterozygous Tfb1+/loxP
mice, which, in turn, were crossed with mice ubiquitously ex-
pressing Cre recombinase under the control of the b-actin
promoter (Figures 1A and 1B). The resulting heterozygous
Tfb1m knockout (Tfb1m+/) mice were intercrossed to obtain
homozygous knockouts (Tfb1m/). However, no live Tfb1m/
mice were born, indicating embryonic lethality. We then pro-
ceeded to analyze staged embryos and recovered mutant
embryos at a frequency of 23% at E8.5. The embryos with
a mutant phenotype were small, the neural cleft was open, no
optic disc was present, and no heart structure was found
(Figure 1C). Genotyping showed that the easily recognizableCell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc. 387
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TFB1M Regulates Mitochondrial TranslationFigure 2. Cardiomyopathy and Mitochondrial Proliferation in TFB1M-Deficient Hearts
(A) Heart weight to body weight ratio in Tfb1mloxP/loxP (control, L/L) and tissue-specific Tfb1m knockout mice (L/L, cre) at different ages in weeks. At 5 weeks: L/L
n = 10, L/L, cre n = 8; 10weeks: L/L n = 5, L/L, cre n = 6; 15weeks: L/L = 6, L/L, cre n = 8; 20weeks: L/L n = 19, L/L, cre n = 16. Error bars indicate SEM; ***p < 0.001;
Student’s t test.
(B) Electron micrographs of heart tissue of 20-week-old control and knockout mice. Scale bar, 2 mm.
(C) Quantification of mitochondrial mass after electron microscopic analysis of heart tissue from control and tissue-specific Tfb1m knockout mice at different
ages. Error bars indicate SEM; *p < 0.05; **p < 0.01; ***p < 0.001; Student’s t test.
(D) Western blot analysis of TFB1M protein levels in heart mitochondrial extracts from control and Tfb1m knockout mice at different ages. *, crossreacting band.mutant embryos (n = 8) were all homozygous knockouts
(Tfb1m/), whereas the remaining normally appearing embryos
(n = 27) had the genotype Tfb1m+/ (n = 20) or Tfb1m+/+ (n = 7).
We performed staining to simultaneously detect the enzyme
activities of cytochrome c oxidase (COX; catalytic subunits en-
coded by mtDNA) and succinate dehydrogenase (SDH; all
subunits nucleus encoded) on tissue sections from Tfb1m+/+
and Tfb1m/ embryos. We found a severe decrease of COX
activity, yet preserved SDH activity, in Tfb1m/ embryos
(Figure 1D). The Tfb1m/ embryos thus have a severe respira-
tory chain deficiency andmutantmorphology anddisplay embry-
onic lethality at E8.5, which are all typical features of embryos
with homozygous disruption of nuclear genes, e.g., Tfam (Lars-
son et al., 1998), PolgA (Hance et al., 2005), or Mterf3 (Park
et al., 2007), needed for mtDNA maintenance and expression.
Tissue-Specific Disruption of Tfb1m Causes
Mitochondrial Cardiomyopathy
We proceeded to study the role of TFB1M in a differentiated
mouse tissue by characterizing hearts from mice with disruption
of the Tfb1m gene in heart and skeletal muscle tissue. These
tissue-specific knockout mice (genotype Tfb1mloxP/loxP +/
Ckmm-cre) had a shorter life span, and all of them died before388 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.24 weeks of age. We determined the ratio of heart weight to
body weight at different ages and found that it was normal until
the age of 15 weeks, and thereafter it increased rapidly in the
knockouts (Figure 2A). Electron microscopy analysis of heart
tissues from end-stage knockouts showed an increase of mito-
chondria with abnormal cristae (Figure 2B). We quantified mito-
chondrial mass in cardiomyocytes and found a progressive
increase from age 10 weeks and onward in the knockouts
(Figure 2C). Western blot analyses of mitochondrial extracts
from knockout hearts showed that TFB1M was drastically
depleted already at 5 weeks (Figure 2D). We found no obvious
signs of mitochondrial dysfunction in skeletal muscle of
Tfb1mloxP/loxP +/Ckmm-cre mice, consistent with our previous
observations that skeletal muscle- and heart-specific disruption
of genes controlling mtDNAmaintenance and expression mainly
results in cardiomyopathy during the short life span when the
animals can be observed (Larsson et al., 1998; Wang et al.,
1999; Park et al., 2007).
Hearts Lacking TFB1M Are Respiratory Chain Deficient
with Increased Mitochondrial Biogenesis
Southern blot analysis of DNA isolated from heart tissues of
control and tissue-specific knockout mice revealed a gradual
Cell Metabolism
TFB1M Regulates Mitochondrial TranslationFigure 3. Increased Levels of mtDNA and TFAM in the Absence of TFB1M
(A) Southern blot analysis of total DNA isolated from control (L/L) and tissue-specific Tfb1 knockout (L/L, cre) hearts at age 20 weeks. mtDNA was detected using
Cox1-specifc DNA probe, and nuclear DNA (loading control, nuDNA) was detected by an 18S rDNA probe followed by autoradiography.
(B) Western blot analysis of heart mitochondrial extracts from control and knockout mice at different ages. TFAM and VDAC (loading control) were detected using
specific polyclonal and monoclonal antisera, respectively.
(C) Quantification of mtDNA levels in heart of control and knockout mice at different ages. At 5 weeks, n = 4; 10 weeks, n = 3; 15 weeks, n = 4; 20 weeks, n = 6.
(D) TFAM steady-state levels were quantified by western immunoblotting in 20-week-old mice (control and knockout) and normalized to the levels of VDAC in the
same samples. TFAM levels in knockout hearts are shown as percentage of the levels in control mice. n = 3. Error bars in (C) and (D) indicate SEM; *p < 0.05; **p <
0.01; ***p < 0.001; Student’s t test.increase in mtDNA steady-state levels in the absence of TFB1M,
reaching maximum in 15- to 20-week-old knockout mice
(Figures 3A and 3C). We performed western blot analyses and
found a gradual increase of TFAM protein levels (Figures 3B
and 3D), consistent with previous experimental work showing
that levels of TFAM protein directly regulate steady-state levels
of mtDNA (Larsson et al., 1998; Ekstrand et al., 2004). Measure-
ment of respiratory chain function and mitochondrial ATP
production rates in hearts of 5- and 20-week-old knockouts
showed a progressive deficiency (Figures S1A and S1B). We
found increased enzyme activities of the mitochondrial matrix
enzyme citrate synthase (Figure S1C), consistent with the
observed increase of mitochondrial mass by electron micros-
copy (Figures 2B and 2C). Most likely, the respiratory chain defi-
ciency secondarily elicits mitochondrial biogenesis as a futile
compensatory response. This assumption is well in line with
numerous reports showing that increased mitochondrial biogen-
esis is a common response in humans and mice with mitochon-
drial disease (Smeitink et al., 2001; Wredenberg et al., 2002;
Wenz et al., 2008).
Deficiency of 12S rRNA despite Increased
Mitochondrial Transcription
Weperformed an extensive survey of steady-state levels of mito-
chondrial transcripts in TFB1M-deficient hearts by northern blot-ting (Figure 4A) and found a dramatic decline of 12S rRNA levels
already in 5-week-old knockouts with constantly low levels over
the whole period of the sampling (Figures 4B and 4C). This
finding suggests that TFB1M may directly modify the 12S
rRNA and thereby influences its stability. The levels of 16S
rRNA and ND1 mRNA were substantially increased, whereas
the other studied mRNAs remained similar to control steady-
state levels (Figures 4B and 4C). The increase in steady-state
levels of ND1 and 16S rRNA can be due to either the increased
stability or increased de novo transcription in the absence of
TFB1M. We therefore proceeded to determine steady-state
levels of mitochondrial tRNAs (Figure 4A), as levels of tRNAs are
much less subject to posttranscriptional control than mRNAs
(Park et al., 2007). The steady-state levels of all studied tRNAs
were elevated in knockout mice, regardless of whether they
were transcribed from the HSP or LSP promoter (Figures 4D
and 4E). These findings are consistent with a global increase of
transcription initiation from the promoters of both strands of
mtDNA. We tested this possibility further by g-32P-UTP labeling
of newly synthesized transcripts and found a several-fold
increase of de novo transcription in isolated mitochondria lack-
ing TFB1M (Figures 5A and 5B). We investigated the expression
of MTERF3, a negative regulator of mammalian mtDNA tran-
scription (Park et al., 2007), and found normal Mterf3 mRNA
levels (Figure S2). However, the MTERF3 protein levels wereCell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc. 389
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TFB1M Regulates Mitochondrial TranslationFigure 4. Variable Steady-State Levels of Mitochondrial Transcripts in TFB1M-Deficient Hearts
(A) Linear map of mouse mtDNA indicating the localization of the genes encoding rRNAs (12S, 16S), some mRNAs (ND1, COX1, ND5, Cyt b, ND6), and some
tRNAs (F, L1, L2, etc.).
(B) Northern blot analysis of RNA, isolated from heart tissues of control (L/L) and knockout (L/L, cre) mice at 20weeks of age (n = 4 for each genotype). Nuclear 18S
rRNA was used as a loading control.
(C) Quantification by northern blot analyses of mitochondrial transcripts from control and tissue-specific knockout mice at different ages. Steady-state levels of
individual transcripts were normalized to the levels of 18S and are shown as percentage from the control. Error bars represent SEM. Number of independent
samples for each genotype was: 5 weeks, n = 4; 10 weeks, n = 5; 15 weeks, n = 4; and 20 weeks, n = 4. Error bars represent SEM; *p < 0.05; **p < 0.01;
***p < 0.001; Student’s t test.
(D) Northern blot analysis ofmitochondrial tRNA steady-state levels in hearts from 20-week-old control (L/L) and knockoutmice (L/L, cre). Number of animals from
each genotype, n = 3. 18S rRNA was used as a loading control.
(E) Quantification of steady-state levels of tRNAs shown as a percentage of the levels in controls after normalization to 18S rRNA levels. Error bars represent SEM;
*p < 0.05; **p < 0.01; ***p < 0.001; Student’s t test.390 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.
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TFB1M Regulates Mitochondrial TranslationFigure 5. Increased Transcription Initiation
in the Absence of TFB1M and Lack of
In Vitro Transcription Inhibition by TFB1M
(A) In organello transcription in heart mitochondria
isolated from 20-week-old control (L/L) and tissue-
specific Tfb1m knockout (L/L, cre) mice. De novo
synthesized transcripts were labeled using
a-32P-UTP and separated by agarose gel electro-
phoresis. COX1 mRNA, present in the mitochon-
drial preparations, was detected using a-32P-
dCTP-labeledCox1-specific DNA probe to assess
levels of steady-state transcripts.
(B) Quantification of the newly synthesized tran-
scription products in control and tissue-specific
knockout heart mitochondria. Number of indepen-
dent samples, n = 3. Error bars represent SEM;
**p < 0.01; Student’s t test.
(C) Western blot analysis of MTERF3 and TFB2M
protein levels in heart mitochondrial extracts iso-
lated from control and Tfb1m knockout mice at
different ages.MTERF3andTFB2Mweredetected
using peptide-specific polyclonal antibodies.
VDAC was used as a loading control.
(D) Transcription assay using S100 mitochondrial
extract and varying concentrations of either
TFB1M or TFB2M. Increasing amounts of purified,
recombinant TFB1M or TFB2M were added to
S100 extracts from HeLa cell mitochondria in the
presence of a-32P-UTP. De novo synthesized
LSP transcripts were detected by autoradiog-
raphy. The in vitro transcription reactions contain:
lanes 1 and 6, 0 fmol; lanes 2 and 7, 250 fmol; lanes
3 and 8, 500 fmol; lanes 4 and 9, 1000 fmol; and
lanes 5 and 10, 2000 fmol of TFB1M or TFB2M,
respectively. Lane C, control reaction (see Experi-
mental Procedures). Transcription products were
detected by autoradiography.
(E) In vitro transcription assay using varying
amounts of recombinant TFB1M or TFB2M pro-
teins. Reactions containing LSP promoter DNA
template (85 fmol), TFAM (2.5 pmol), RNAPOL
(400 fmol) copurified with TFB1M or TFB2M
(RNAPOL-TFB1M or RNAPOL-TFB2M, respec-
tively), and either TFB1M (400 fmol) or TFB2M (400 fmol) were supplemented with varying amounts of recombinant TFB2M or TFB1M: lanes 1 and 6, 100 fmol;
lanes 2 and 7, 200 fmol; lanes 3 and 8, 400 fmol; lanes 4 and 9, 800 fmol; and lanes 5 and 10, 1600 fmol. Labeling was carried out in the presence of a-32P-
UTP, and transcription products were detected by autoradiography.decreased (Figure 5C), consistent with posttranslational regula-
tion of the activity of this repressor. In addition, the expression of
the TFB2M protein was increased (Figure 5C). The observed
increase of mitochondrial transcription is thus probably regu-
lated byMTERF3 and TFB2M and is likely part of a mitochondrial
biogenesis response induced by the severe respiratory chain
deficiency accompanying TFB1M deficiency, as discussed
above.
TFB1M Does Not Repress mtDNA Transcription In Vitro
It has been reported that addition of recombinant TFB1M protein
to mitochondrial extracts dramatically stimulates mtDNA tran-
scription (McCulloch et al., 2002; McCulloch and Shadel,
2003). These findings seem inconsistent with our results, as we
found dramatically increased transcription of mtDNA after
genetic ablation of TFB1M in the mouse heart (Figure 5A). We
therefore repeated the experiments previously published by
others (McCulloch et al., 2002; McCulloch and Shadel, 2003),and we were surprised to find no increase of in vitro transcription
after addition of recombinant TFB1M to mitochondrial extracts
(Figure 5D). It should bementioned that the TFB1Mprotein prep-
aration we used for this experiment has transcription initiation
activity in the pure recombinant in vitro transcription system (Fal-
kenberg et al., 2002). We also ensured that the mitochondrial
extract we used was active by demonstrating that addition of
recombinant TFB2M resulted in a dramatic increase of in vitro
transcription (Figure 5D).
It is a formal possibility that TFB1M may compete with
TFB2M by acting as a transcriptional repressor, which would
explain the observed increase of mtDNA transcription in
Tfb1m knockout mice. We have previously addressed this issue
in a series of unpublished experiments and found no evidence
that TFB1M represses transcription. However, given the impor-
tance of this issue, we repeated these in vitro transcription
experiments with mtDNA promoter templates and pure re-
combinant TFB1M, TFB2M, POLRMT, and TFAM proteinsCell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc. 391
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TFB1M Regulates Mitochondrial TranslationFigure 6. Reduced Formation of Respiratory Chain Enzymes Due to Inhibited Mitochondrial Translation in the Absence of TFB1M
(A) Steady-state levels of mitochondrial- and nuclear-encoded subunits of the respiratory chain complexes detected by immunoblotting of mitochondrial extracts
from control (L/L) and tissue-specific Tfb1m knockout (L/L, cre) hearts at different ages. ND5 (complex I), COX1, and COX2 (complex IV) are encoded and trans-
lated in mitochondria, whereas the SDHA (complex II) is nuclear encoded.
(B) Levels of assembled respiratory chain enzyme complexes analyzed by BN-PAGE of mitochondrial extracts from control and tissue-specific Tfb1m knockout
mice at different ages.
(C) Mitochondrial translation in isolated heart mitochondria from control (L/L) and knockout (L/L, cre) mice at 20 weeks of age. Mitochondrial translation products
were labeled using Redivue L-[35S]-Methionine and detected by autoradiography after SDS-PAGE and transfer on nitrocellulose membranes. VDAC was
detected by western immunoblotting (IB) and used as a loading control for steady-state levels of proteins in the mitochondrial extract.
(D) Levels of newly synthesized COX1 and COX2 in knockout mitochondria shown as percentage from the corresponding levels in control mitochondria. The
signals for COX1 and COX2 in both genotypes were normalized to the signal for VDAC as detected by immunoblotting. Number of samples for each genotype,
n = 3. Error bar indicates SEM; ***p < 0.001; Student’s t test.(Figure 5E). We confirmed our previous finding that TFB2M is
several orders of magnitude more active than TFB1M in
promoting transcription initiation in this system (Falkenberg
et al., 2002). We tested the possibility that TFB1M may act as
a transcriptional inhibitor by adding excess recombinant
TFB1M to transcription reactions containing TFB2M. We found
no evidence that a molar excess of TFB1M can inhibit a tran-
scription reaction dependent on TFB2M (Figure 5E, right panel).
Consistent with these findings, we found strong activation of
transcription when we added excess recombinant TFB2M to
transcription reactions containing TFB1M (Figure 5E, left panel).
Based on these results, we conclude that the observed
increase of mitochondrial transcription in Tfb1m knockout
mice is not explained by a transcription repression role for
TFB1M.392 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.Loss of TFB1M Severely Impairs Mitochondrial
Translation
Western blot analyses of mitochondrial extracts from control and
tissue-specific knockout mice revealed a gradual decrease in
the steady-state levels of the mitochondrially encoded respira-
tory chain subunits ND5 (complex I), COX1, and COX2 (complex
IV), whereas levels of the nuclear SDHA (complex II) subunit
remained unchanged (Figure 6A). We assessed levels of assem-
bled respiratory chain complexes with BN-PAGE analyses and
found a defective assembly of complex I, III, and IV and, to
a lesser extent, complex V in 20-week-old tissue-specific
Tfb1m knockout mice (Figure 6B), consistent with the observed
decrease in respiratory chain function and mitochondrial ATP
rates (Figures S1A and S1B). We investigated the cause for
this reduction in levels of mtDNA-encoded respiratory chain
Cell Metabolism
TFB1M Regulates Mitochondrial Translationsubunits by performing translation assays with mitochondria
isolated from control and tissue-specific knockout hearts. Auto-
radiographic analysis of newly synthesized mitochondrial trans-
lation products showed severely impaired translation (>90%
decrease) in mitochondria from 20-week-old tissue-specific
Tfb1m knockout mice (Figures 6C and 6D).
Decreased Methylation of 12S rRNA Impairs
Stability of the Small Ribosomal Subunit
We performed primer extension analyses to check for the pres-
ence of adenine dimethylation in the hairpin loop at the 30 end of
12S rRNA (Figure 7A), as previously described (Lafontaine et al.,
1995, 1998). Due to the decrease in the steady-state levels of
12S rRNA, our primer extension assay estimates the degree of
methylation on the remaining rRNA molecules. We found
a severe decrease of the primer extension stop in end-stage
knockouts, demonstrating that loss of TFB1M completely abol-
ishes 12S rRNA adenine dimethylation (Figures 7B and 7C).
This finding also demonstrates that TFB2M or other enzymes
cannot compensate for the severe loss of methyltransferase
activity that occurs in Tfb1m knockouts. Methylation of 12S
rRNA was only mildly reduced at 5 weeks of age (Figure 7C)
despite the profound depletion of TFB1M protein at the same
age (Figure 2D). These findings suggest that turnover of methyl-
ated 12S rRNAmay take several weeks, and the Tfb1m knockout
animals will likely not manifest a major phenotype until most of
the methylated 12S rRNAs have been turned over.
Next, we examined the steady-state levels of proteins from the
28S and the 39S ribosomal subunits of the mammalian mito-
chondrial ribosome by using western blot analyses (Figure 7D).
MRPS15, homologous to E. coli Rps15 (Cavdar Koc et al.,
2001), and MRPS16 are both protein components of the small
ribosomal subunit and were present at decreased steady-state
levels in 10-, 15-, and 20-week-old Tfb1m knockout mice
(Figure 7D). In contrast, MRPL13 and MRPL48, which are both
protein components of the large ribosomal subunit, were present
at increased levels in Tfb1m knockouts (Figure 7D), in good
agreement with the observed increase of steady-state levels of
16S rRNA (Figures 4B and 4C). In 5-week-old knockouts,
MRPS15 was increased in abundance, which may represent
a compensatory increase in its expression in response to an
emerging translational deficiency.
We carried out gradient sedimentation analyses of mitochon-
drial extracts from knockout and control mice to investigate the
integrity of the mitochondrial ribosome (Figure 7E). With this
method, we detected the 28S and 39S subunits and the 55S
assembled mitochondrial ribosome as determined by western
blot analyses of gradient fractions (Figure 7E). We used
MRPS15 as amarker for the 28S ribosomal subunit and comigra-
tion of MRPL13 and MRPL48 as markers for the 39S subunit.
Comigration of MRPS15, MRPL13, and MRPL48 were used as
markers for the assembled 55S mitochondrial ribosome. Anal-
yses of ribosome assembly patterns in Tfb1m knockout mice
showed a deficiency of assembled small ribosomal subunits
(Figure 7E). Based on these results, we conclude that absence
of adenine dimethylation in 12S rRNA causes a specific loss of
28S subribosomal particles, whereas 39S subunits are assem-
bled and present at increased steady-state levels. Although we
cannot exclude the possibility that individual proteins from the39S subunits are absent, our results suggest that the assembly
and stability of 39S particles is mostly independent of the pres-
ence of assembled small ribosomal subunits. We analyzed the
distribution of TFB1M protein by gradient sedimentation anal-
yses of mitochondrial extracts from control mice and found
that a fraction of TFB1M was associated with the small subunit
of the ribosome (Figure 7F), consistent with the above described
role in 12S rRNA methylation.
DISCUSSION
The functional role of adenine dimethylation at the 30 end of the
rRNA situated in the small ribosomal subunit appears to be rela-
tively limited in unicellular organisms, despite the extremely high
conservation in all domains of life (Shutt and Gray, 2006). In
E. coli, lack of the KsgA methyltransferase leads to resistance
to the aminoglycoside kasugamycin and only marginal growth
retardation (Helser et al., 1971; Poldermans et al., 1979; van
Buul et al., 1984). In S. cerevisiae, adenine dimethylation is
dispensable in vivo, as Dim1p mutant yeast cells grow normally
despite the absence of cytoplasmic rRNA adenosine dimethyla-
tion (Lafontaine et al., 1998). In vitro experiments with extracts
from KsgA-deficient E. coli cells have shown decreased affinity
between the ribosomal subunits (Poldermans et al., 1980) and
aberrant regulation of in vitro translation (Poldermans et al.,
1979), consistent with the observation that the dimethylated
adenines are present at the interface of the two ribosomal
subunits (Xu et al., 2008).
In contrast to these earlier studies in unicellular organisms, we
show here that the dimethylation of a stem-loop structure of 12S
rRNA is of critical importance for normal function and integrity of
the mammalian mitochondrial ribosome. The gene encoding the
TFB1M methyltransferase is essential for embryonic develop-
ment in mouse. Loss of function of TFB1M in a differentiated
tissue, such as heart, leads to loss of dimethylation on A1006
and A1007 of 12S rRNA, decreased steady-state levels of 12S
rRNA, instability of the small subunit of the ribosome, and abol-
ished mitochondrial translation.
Lack of dimethylation on 12S rRNA leads to a drastic decrease
in levels of assembled 28S ribosomal subunits, whereas the
levels of the 39S subunits are increased. It is therefore possible
that 12S rRNAmethylation is a mandatory step in the biogenesis
of the 28S subunit. However, this hypothesis is not supported by
results from studies in bacteria, because functional bacterial
ribosomes can be assembled and are stable in the absence of
rRNA dimethylation (Poldermans et al., 1979, 1980). Another
possibility is that the 28S subunit is formed normally but
becomes unstable in the absence of rRNA dimethylation. It has
been shown that KsgA is able to bind assembled bacterial small
(30S) ribosomal subunits, which could provide a checkpoint
mechanism prior to assembly of fully active ribosomes (Desai
and Rife, 2006; Xu et al., 2008). It is possible that KsgA binding
could ensure that only 30S subunits that are translationally
competent are present in fully assembled ribosomes (Desai
and Rife, 2006; Xu et al., 2008). We found cosedimentation of
TFB1M and the small ribosomal subunit, and it is therefore
possible that TFB1M functions in a manner similar to KsgA and
binds the interface between the mitochondrial ribosomal
subunits to provide a checkpoint prior to initiation ofCell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc. 393
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TFB1M Regulates Mitochondrial TranslationFigure 7. Loss of 12S rRNA Dimethylation Results in Reduced Steady-State Levels of the Small Ribosomal Subunit in Tissue-Specific
Knockout of Tfb1m
(A) Experimental set up for measuring the presence of dimethylation on A1006 and A1007 residues in 12S rRNA (counted from the 50 end of tRNA-Phe). A set of
two primers (MM49 andMM13) was used for primer extension. MM49 (12 bases) is complementary to a region close to the 50 end of 12S rRNA, and its extension
product (P1; 46 bases) was used as a 12S rRNA loading control. MM13 (12 bases) is complementary to a region positioned downstream of the dimethylated
A1006 and A1007 (shown in bold capital letters). Extension of this primer is inhibited by the presence of methylation and leads to accumulation of an extension
product P2 (17 bases).
(B) Primer extension analysis of 12S rRNA in RNA samples isolated from heart tissues of control (L/L) and knockout (L/L,cre) mice at 20 weeks of age. RNA from
knockout mice was used in 2-fold excess of RNA from control mice. Control reactions using MM13 or MM49 alone are shown. *, a putative precursor form of 12S
rRNA.
(C) Relative ratio between primer extension products P2 and P1 in RNA samples from control and tissue-specific Tfb1m knockout mice at different ages.
Error bars represent SEM. Number of independent samples from each genotype: 5 weeks, n = 3; 10 weeks, n = 3; 15 weeks, n = 4; 20 weeks, n = 3. *p < 0.05;
***p < 0.001; Student’s t test.
(D) Steady-state levels of proteins from the small (28S) and large (39S) ribosomal subunits, detected by western immunoblotting of mitochondrial extracts from
control and tissue-specific Tfb1m knockout mice at different ages. MRPS15 and MRPS16 are subunits of the 28S ribosomal particle. MRPL13 and MRPL48 are
subunits from the 39S ribosomal particle. VDAC was used as a loading control.
(E) Sedimentation analysis of 28S and 39S subribosomal particles by centrifugation through linear 10%–30% sucrose density gradient. The migration of both
ribosomal particles was determined by immunoblotting for MRPS15, MRPL13, and MRPL48 after SDS-PAGE. Representative from three independent experi-
ments is shown. Fraction numbers are indicated.394 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.
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TFB1M Regulates Mitochondrial Translationmitochondrial translation. This model predicts that 28S subunits
with unmethylated 12S rRNA will fail to interact with the 39S
subunit and instead will be degraded.
The results presented here are inconsistent with previous
reports suggesting that TFB1M is a strong transcriptional acti-
vator (McCulloch et al., 2002; McCulloch and Shadel, 2003). If
TFB1M indeed would be a strong transcription factor, knockout
of the Tfb1m gene should lead to decreased mtDNA transcrip-
tion. However, at variance with this prediction, we instead report
that loss of TFB1M leads to increased transcription initiation.
Transcription from both mtDNA promoters, LSP and HSP,
generates polycistronic transcripts that are processed to release
the individual mRNAs and tRNAs. The steady-state levels of
mRNAs are much more subjected to posttranscriptional control
than the steady-state levels of tRNAs (Park et al., 2007). In line
with this prediction, we found normal or near normal steady-
state levels of most mRNAs, except for the ND1mRNA, whereas
the steady-state levels of all tRNAs were significantly increased.
Importantly, the levels of tRNAs were increased regardless of
whether the corresponding gene was transcribed from the LSP
or HSP promoter. In vitro transcription experiments indeed
confirmed a strong activation of de novo transcription in mouse
heart mitochondria lacking TFB1M. The observed reduction of
MTERF3 protein, a known repressor of mtDNA transcription
(Park et al., 2007), and increase of TFB2M protein provide
a mechanism to explain the increased mtDNA transcription in
TFB1M knockouts. We also provide evidence that TFB1M
does not act as a transcriptional repressor that competes with
TFB2M in vitro. Instead, we find it likely that the increased
mitochondrial transcription is part of a secondary response to
increase mitochondrial biogenesis as a cellular attempt to
compensate for the severe respiratory chain deficiency caused
by the abolished mitochondrial translation in the absence of
TFB1M. Consistent with this interpretation, we report
a concerted increase of mitochondrial mass, mtDNA, TFAM,
and mtDNA transcription in the TFB1M-deficient hearts. Such
an increase of mitochondrial biogenesis is a well-documented
response in animals and humans with respiratory chain defi-
ciency (Larsson et al., 1998; Wredenberg et al., 2002; Park
et al., 2007; Scarpulla, 2008). Based on our data, we propose
that TFB1M functions as an important regulator of ribosomal
biogenesis in mammalian mitochondria. We further propose
that activation of the expression of the nuclear genes encoding
TFB1M and TFB2M is a central component of the mitochondrial
biogenesis response to ensure that there is a concerted increase
of both mitochondrial transcription and translation to increase
the expression of the essential mtDNA-encoded respiratory
chain subunits. This hypothesis could be tested by performing
correlative studies in mammalian tissues induced to increase
mitochondrial biogenesis. More importantly, experimental
studies aimed at simultaneously regulating the expression of
both TFB1M and TFB2M in mice should be performed.
Increased understanding of molecular mechanisms regulatingmtDNA expression may well lead to the opening of novel
avenues leading toward treatment of age-associated diseases
and amelioration of aging.
In summary, we show here that TFB1M is an essential dime-
thyltransferase in mammalian mitochondria that dimethylates
adenines at the 30 end of 12S rRNA. We present evidence that
this modification is essential for the stability of the small subunit
of the mitochondrial ribosome. In addition, our study provides
a possible explanation for the universal conservation of adenine
dimethylation of the small subunit rRNA in a variety of organisms
and presents evidence for a critical role in regulating ribosome
maintenance and translation.
EXPERIMENTAL PROCEDURES
Generation of Conditional Tfb1m Knockout Mice
Wedesigned a targeting vector with exon III of the Tfb1m locus, flanked by two
loxP sites, to generate conditional knockout Tfb1mmice (Figure 1A). Genomic
clones containing mouse Tfb1m were isolated from a 129Sv RPCI-22M BAC
Library (Invitrogen). DNA fragments containing exon III and exon IV of the
Tfb1m locus were isolated from BAC clones using XhoI-BamHI and BamHI
endonuclease digestion, respectively. pBluescript II SK+ (pBS; Stratagene)
vector was modified by ligation with oligonucleotides containing XhoI and
BamHI restriction sites to create the pNH7 plasmid. In pNH7, sites not compat-
ible with downstream cloning steps were thus eliminated. A DNA fragment
containing exon III of Tfb1m was cloned into the BamHI-XhoI sites of the
pNH7 vector to create the pNH10 plasmid. The BamHI genomic fragment con-
taining exon IV of Tfb1m was cloned into the BamHI site of pBluescript II SK+,
giving rise to the pNH9 plasmid. Next, pNH10 was linearized with XbaI, and
a loxP sequence was introduced upstream of exon III by ligation with oligonu-
cleotides containing this sequence, thus generating vector pNH11. A DNA
fragment containing the neomycin resistance gene and a loxP site was cloned
into pNH10 using AatII and ClaI endonuclease restriction sites, resulting in
vector pNH12. Oligonucleotides containing NotI and SalI restriction sites
were ligated into a ClaI-PacI-digested pNH12 vector. The resulting pNH13
vector was digested using NotI and SalI endonucleases. Finally, the DNA frag-
ment containing exon IV was isolated from pNH9 using NotI-SalI endonu-
clease digestion and cloned into linearized pNH13. This construct, pNH14,
was linearized using SalI endonuclease and electroporated in 129R1 ESCs.
Targeted clones were identified by SpeI restriction digestion of genomic
DNA and hybridization with an a-32P-dCTP-labeled probe located outside of
the targeted region. Positive ESC clones were used for blastocyst injection,
and germline transmission was obtained by mating the chimeric mice to
B6C57 mice. The PKG-neo gene was removed by mating Tfb1m+/loxP-neo
mice to mice ubiquitously expressing Flp recombinase (Rodriguez et al.,
2000), thus generating Tfb1m+/loxP mice. These mice, in turn, were mated to
mice ubiquitously expressing Cre recombinase (b-actin-cre) (Larsson et al.,
1998) to obtain heterozygous knockout (Tfb1m+/) mice.
Tissue-Specific Knockout of Tfb1m
Heart- and skeletal muscle-specific knockout mice were generated as
described previously (Larsson et al., 1998; Hance et al., 2005; Park et al.,
2007). Briefly, heterozygous Tfb1m+/loxP mice were mated to heterozygous
transgenic mice expressing Cre recombinase under the control of a heart-
and muscle-specific promoter (+/Ckmm-cre). Mice with the genotype
Tfb1m+/loxP, +/Ckmm-cre were recovered from this cross and mated to
Tfb1mloxP/loxP mice to generate Tfb1mloxP/loxP, +/Ckmm-cre (tissue-specific
knockouts) and Tfb1mloxP/loxP (control) mice.(F) Sedimentation analysis of heart mitochondrial extracts from wild-type (WT) mice by centrifugation through linear 10%–30% sucrose density gradient. The
partial comigration of TFB1M and the small ribosomal subunit was determined by immunoblotting with specific antibodies after SDS-PAGE. MRPS15 was
used as amarker for the sedimentation of the small ribosomal subunit. TFAMwas used as a negative control. TFB1M is the lower band in the upper panel; a cross
reacting band is indicated by *.Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc. 395
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For the determination of mtDNA levels, total DNA was isolated using the
DNeasy Blood & Tissue Kit (QIAGEN), and 1 mg DNA was digested with SacI
endonuclease. The digested DNA was electrophoresed in agarose, blotted,
and hybridized to a-32P-dCTP-labeled probes to detect mtDNA (CoxI probe)
and nuclear DNA as loading control (18S rDNA probe).
RNA for northern blot analyses was isolated using the ToTALLY RNA Total
RNA isolation kit (catalogue number AM1910; Ambion) and resuspended in
formamide. Samples of 1–2 mg RNA were electrophoresed in formaldehyde
agarose gels and transferred to Hybond-N+membranes (GE Healthcare). Indi-
vidual RNA species were detected using a-32P-dCTP-labeled DNA probes.
Different tRNAs were detected using specific oligonucleotides labeled with
g-32P-dATP (Park et al., 2007). Quantifications of Southern and northern blots
were performed after autoradiographic detection using Molecular Imager FX
(Bio-Rad).
Rabbit polyclonal antisera were used for detection of the TFAM, COX1,
COX2, and ND5 proteins. Antisera specific for NDUFA9 (complex III), SDHA
(70 kDa subunit of complex II), F1a (complex V), and subunit IV (complex IV)
were purchased from Molecular Probes (Eugene, OR). VDAC (Porin) anti-
bodies were purchased from Calbiochem (San Diego; CA). Mouse polyclonal
MRPL48-specific antiserum was purchased from the Abnova Corporation.
Polyclonal antisera against mouse TFB1M, TFB2M, and MRPS15 were gener-
ated in rabbits by using a single peptide or a mixture of two peptides corre-
sponding to each protein (TFB1M: N-MAASGKLGTFRLC-C andN-CFTYNFRE
ELKOKKS-C; TFB2M: N-CIEPLPDSDLEESSPWTSRNRS-C; MRPS15: N-KIL
RQTNYDVFEKTC-C and N-CPENPSNAVPEKTQVN-C). Antisera against
TFB1M and TFB2M were additionally purified by immunoadsorption using
the antigenic peptides. The MTERF3 polyclonal antibody was generated as
described previously (Park et al., 2007). The MRPL13 antiserum was provided
by Doctor Linda Spremulli and the MRPS16 rabbit polyclonal antibody by
Doctor Ann Saada. Quantifications of chemiluminescent signals were per-
formed using a CCD camera (Bio-Rad).
Mitochondrial Isolation and In Organello Translation
Mitochondria were isolated by differential centrifugation in isolation buffer A
(320 mM sucrose, 10 mM Tris-HCl, 1 mM EDTA [pH 7.4]). After three washes
with isolation buffer, mitochondria were either used immediately or stored at
80C for later use. Mitochondria for in organello translation were isolated in
isolation buffer B (220 mM mannitol, 70 mM sucrose, 20 mM HEPES, 2 mM
EGTA, 0.1% BSA [pH 7.4]) (Mattiazzi et al., 2002). Translation in isolated mito-
chondria was performed as described previously, with some modifications
(Cote et al., 1989). Mitochondria (100 mg) were resuspended in translation
buffer EGS+ (Cote et al., 1989) containing 60 mg/ml of each amino acid, minus
methionine, and incubated for 5 min at 30C. Redivue L-[35S]-Methionine (GE
Healthcare) was added to 0.5 mCi/ml to the mitochondrial suspension, and
translation was allowed to proceed for 40 min at 30C. Mitochondria were
reisolated by centrifugation (5 min/70003 g/4C) and washed twice with
isolation buffer A. Mitochondrial pellets were resuspended in SDS-PAGE
loading buffer and subjected to SDS-PAGE. Labeled mitochondrial translation
products were transferred on Hybond-C Extra nitrocellulose membranes (GE
Healthcare) and detected by autoradiography.
Sucrose Density Gradient Analysis of 28S
and 39S Ribosomal Subunits
Sucrose density gradient analysis of ribosomal subunits was performed as
described in Matthews et al., 1982, with modifications. Heart mitochondria
(1.2 mg), isolated in isolation buffer A without EDTA and supplemented with
Complete EDTA-free Protease Inhibitor Cocktail (Roche), were reisolated by
centrifugation (10 min/93003 g/4C) and resuspended at concentration
10 mg/ml in lysis buffer (260 mM sucrose, 100 mM KCl, 20 mM MgCl2,
10 mM Tris-HCl [pH 7.5], 5 mM b-mercaptoethanol, 1% Triton X-100) supple-
mented with Complete EDTA-Free Protease Inhibitor Cocktail (Roche). After
incubation for 20 min on ice, lysates were cleared by centrifugation (45 min/
93003 g/4C). The subribosomal particles in 100 ml of cleared mitochondrial
lysate were separated by sedimentation through 10%–30% linear sucrose
gradients by centrifugation for 15 hr at 71,0003 g (4C). Gradients were
prepared in buffer A without Triton X-100. Gradients were formed using
Gradient Master (Biocomp Instruments, Inc.) in 143 89mmUltra-Clear centri-396 Cell Metabolism 9, 386–397, April 8, 2009 ª2009 Elsevier Inc.fuge tubes (Beckman Instruments, Inc.) according to instructions in the oper-
ator’s manual provided for Gradient Master. Prior to loading of the samples,
a single 400 ml fraction was removed from the top of the gradients to prevent
sample losses incurred during the acceleration and deceleration phase of the
centrifugation. Fractions (750 ml) were collected from the top of the gradients,
and proteins in each fraction were precipitated with trichloracetic acid and
subjected to SDS-PAGE followed by immunoblotting. Subribosomal particles
were detected using antisera specific for individual proteins from the 28S and
39S ribosomal subunits.
Primer Extension Analysis
Primer extension analyses were performed using a pair of primers in each
primer extension reaction: MM49 (12 bases, 50-GTGTAATTTTAC-30) comple-
mentary to a sequence close to the 50-end of 12S rRNA, whose extension
product (46 bases) was used as a loading control, andMM13 (12 bases, 50-ATT
ATTCCAAGC-30 ) complementary to a region downstream of the 30 end of 12S
rRNA, close to the dimethylated A1006 and A1007. Primers were labeled with
g-32P-ATP by using T4 polynucleotide kinase. Labeled primers were purified
using MicroSpin G-25 chromatography columns (GE Healthcare) and an-
nealed to RNA from heart tissue of control and tissue-specific Tfb1m knockout
mice. Reactions were incubated at 65C for 5 min and placed on ice. M-MuLV
Reverse Transcriptase (Stratagene) was added to 5 U/ml together with dNTPs
(0.25 mM/ml each). The reactions were incubated for 1 hr at 37C. Extension
products were precipitated and resuspended in loading buffer (formamide,
1 mg/ml bromphenol blue, 1 mg/ml xylene cyanol, 10 mM EDTA [pH 8.0]).
Primer extension products were resolved using denaturing Urea-PAGE and
detected by autoradiography. To compensate for the decrease in the 12S
rRNA levels, RNA isolated from tissue-specific Tfb1m knockout mice was
used in a 2- to 3-fold excess in comparison with control samples.
In Vitro Transcription, Transcription in S100 Mitochondrial
Fraction, and Transcription in Isolated Mitochondria
Mitochondrial S100 fractions were isolated as described previously (Micol
et al., 1996). Recombinant POLRMT, TFAM, TFB1M, and TFB2Mwere purified
as described previously (Falkenberg et al., 2002). Transcription reactions with
S100 extracts were carried out using varying amounts of recombinant TFB1M
or TFB2M. Control reactions were carried out in the presence of 85 fmol
LSP-containing DNA template and recombinant TFB2M (500 fmol), TFAM
(2.5 pmol), and POLRMT (500 fmol) instead of S100 mitochondrial extracts.
In vitro transcription reactions were carried out essentially as previously
described (Falkenberg et al., 2002). Transcription in isolated mitochondria (in
organello) was performed as described previously (Enriquez et al., 1996;
Park et al., 2007).
Biochemistry, BN-PAGE, and Electron Microscopy
BN-PAGE was performed as described in Park et al., 2007. Respiratory chain
enzyme activities andMAPR were measured in mitochondria isolated from the
left ventricle tissue as described (Wibomet al., 2002). Electronmicroscopy and
quantification of mitochondrial volume density was performed as described
(Park et al., 2007).
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